Felicis Ventures, established in 2006 and based in Menlo Park, California, is a venture capital firm that invests in early-stage, innovative companies. The firm focuses on backing founders who are building transformative businesses across various sectors, including AI, health, and security. Felicis provides more than just capital, offering active mentoring and advisory services to support its portfolio companies. Since inception, Felicis has invested in over 120 technology companies, with 50 having been acquired or gone public.
Prenuvo, Inc. specializes in whole-body magnetic resonance imaging (MRI) services aimed at early detection of solid tumors and other medical conditions. Founded in 2018 and headquartered in Vancouver, Canada, the company operates preventative screening clinics in Vancouver and Silicon Valley, California. Prenuvo employs advanced MRI technology that provides high-quality, multiparametric imaging for various diagnostic purposes, including cancer and diseases affecting the brain, thorax, abdomen, liver, reproductive organs, and spine. This innovative approach allows for clinically accurate and affordable early symptom detection, serving both patients and the pharmacology sector by enhancing precision in medical imaging.
Observo AI
Seed Round in 2025
Observo AI is a technology company that specializes in AI-driven observability solutions for security and DevOps teams. Its core product is an intelligent observability pipeline that optimizes telemetry data, reducing costs by up to 50% and accelerating incident resolution by over 40%. This is achieved through features such as intelligent data reduction, anomaly detection, and real-time insights, helping teams manage data sprawl and improve operational efficiency.
Clear Labs
Series D in 2025
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.
DatologyAI
Series A in 2024
DatologyAI is an AI-data curation startup focused on developing deep learning tools that facilitate automatic selection in data training. The company offers solutions that automate the creation of datasets by identifying the most relevant information based on the specific needs of the AI model. Its technology employs modality-agnostic algorithms capable of detecting redundant, noisy, or harmful data points, without the need for labels, making it applicable across various industries. Additionally, DatologyAI's tools suggest methods for augmenting existing datasets and optimizing the organization of data, ultimately streamlining the model training process and reducing costs for clients.
MotherDuck
Series B in 2023
MotherDuck specializes in data infrastructure and analytics, providing a serverless platform designed to handle both small and large datasets. By integrating the performance of DuckDB with cloud capabilities, the company offers a user-friendly solution that facilitates collaborative data analysis. Its platform employs an embedded database to support hybrid execution, allowing users to analyze data locally and remotely. This enables businesses to effectively prototype and optimize their data strategies, enhancing their ability to derive insights and maximize profits in a streamlined environment.
MadKudu
Series A in 2022
MadKudu Inc. is a software company based in Mountain View, California, founded in 2014. It specializes in predictive lead scoring solutions tailored for high-volume B2B SaaS companies. MadKudu's platform analyzes customer behavior and integrates it with public data, enabling users to generate insightful reports and share them with their teams. By operationalizing data science, the platform helps clients make informed decisions and drive significant revenue growth. Additionally, MadKudu's tools facilitate the conversion of free users into paying customers and include features such as a monthly recurring revenue simulator.
Prenuvo
Series A in 2022
Prenuvo, Inc. specializes in whole-body magnetic resonance imaging (MRI) services aimed at early detection of solid tumors and other medical conditions. Founded in 2018 and headquartered in Vancouver, Canada, the company operates preventative screening clinics in Vancouver and Silicon Valley, California. Prenuvo employs advanced MRI technology that provides high-quality, multiparametric imaging for various diagnostic purposes, including cancer and diseases affecting the brain, thorax, abdomen, liver, reproductive organs, and spine. This innovative approach allows for clinically accurate and affordable early symptom detection, serving both patients and the pharmacology sector by enhancing precision in medical imaging.
Explo
Series A in 2022
Explo is a data exploration and analysis platform founded in 2019 and headquartered in San Francisco, California. The platform enables users to connect directly to various database and data warehouse sources, allowing them to explore, analyze, and visualize data easily through a user-friendly point-and-click interface. By integrating with any data source, Explo facilitates data manipulation and visualization without requiring SQL knowledge, empowering clients to make informed, data-driven decisions to enhance their business growth and scalability.
Dedrone
Series C in 2022
Dedrone GmbH specializes in drone detection solutions aimed at enhancing security against unauthorized aerial intrusions. Established in 2014 and headquartered in Kassel, Germany, the company offers its flagship product, DroneTracker, a multi-sensor system designed to identify and monitor unmanned aerial vehicles. This platform serves critical sectors such as data centers, airports, and prisons, providing early warnings of potential threats related to corporate espionage, smuggling, and terrorism. Utilizing machine learning and data fusion technology, Dedrone's system allows clients to customize their security measures according to their specific needs and threat levels. The company's products are distributed globally, addressing the growing vulnerabilities associated with advancements in consumer and commercial drone technology.
PicnicHealth
Series C in 2022
PicnicHealth is a company focused on simplifying access to medical records and utilizing data to advance medical research. It provides patients with a secure online dashboard that consolidates their medical records from various healthcare providers across the United States. This innovative platform allows individuals to manage their health information efficiently while also giving them the option to contribute their anonymized data for scientific research. By doing so, PicnicHealth enables life sciences researchers to gain insights into real-world disease management and treatment practices, enhancing the understanding of patient experiences beyond traditional clinical trials. The company has successfully assisted tens of thousands of patients and established partnerships with major biopharmaceutical firms, positioning itself as a key player in the evolving healthcare landscape.
Synaptic
Series B in 2022
Synaptic is a data platform that provides actionable insights to investors by integrating a diverse range of alternative data sources into a single, no-code interface. The platform is designed to optimize investment strategies by enabling users to track portfolio companies, competitors, and sectors while utilizing advanced tools and algorithms to analyze large datasets. This approach helps identify patterns, trends, and anomalies, allowing investors and fund managers to discover opportunities, manage risks, and improve overall investment performance. Synaptic serves a global clientele that includes top venture capital firms, private equity firms, and hedge funds, leveraging various data types such as app usage, marketing metrics, employee insights, product reviews, gaming trends, search patterns, funding activities, and company firmographics to enhance the research workflow from sourcing to due diligence.
proton.ai
Series A in 2022
Proton.ai is an artificial intelligence-driven sales platform tailored for distributors, aimed at enhancing revenue and market share. Developed by professionals with a deep understanding of the distribution industry, the platform leverages advanced algorithms to predict customer preferences and suggest products that customers are likely to purchase based on their past buying behavior. This capability allows sales representatives to operate more effectively, facilitating improved engagement with clients and driving e-commerce growth. By focusing on the unique needs of business-to-business distributors, Proton.ai empowers firms to optimize their sales strategies and better understand customer choices.
Dedrone
Series C in 2021
Dedrone GmbH specializes in drone detection solutions aimed at enhancing security against unauthorized aerial intrusions. Established in 2014 and headquartered in Kassel, Germany, the company offers its flagship product, DroneTracker, a multi-sensor system designed to identify and monitor unmanned aerial vehicles. This platform serves critical sectors such as data centers, airports, and prisons, providing early warnings of potential threats related to corporate espionage, smuggling, and terrorism. Utilizing machine learning and data fusion technology, Dedrone's system allows clients to customize their security measures according to their specific needs and threat levels. The company's products are distributed globally, addressing the growing vulnerabilities associated with advancements in consumer and commercial drone technology.
Clear Labs
Series C in 2021
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.
Feel Therapeutics
Seed Round in 2021
Feel Therapeutics is a digital precision medicine company focused on improving mental health through objective data and passive monitoring. It develops physiological and digital biomarkers alongside therapeutics that aid in the diagnosis, management, and care of mental health conditions. The company's platform includes proprietary medical-grade wearables, such as a wristband equipped with five embedded sensors, which collect biometric data. This data is analyzed using advanced computational methods to create digital biomarkers. By integrating these technologies, Feel Therapeutics aims to provide users with evidence-based insights that enhance their mental well-being and foster the development of lasting positive emotional habits.
January AI
Venture Round in 2021
January AI, founded in 2017 by Noosheen Hashemi, is a precision health start-up based in Menlo Park, California. The company focuses on empowering individuals to take control of their health by utilizing multi-omic science and artificial intelligence. January AI develops a platform that offers personalized biological insights, enabling users to understand their health through a suite of software and consumer products. One of its key innovations is a virtual continuous glucose monitor that provides real-time glucose insights and predictions, utilizing data from heart rate and glucose levels. This approach allows users to align their health habits with their unique biological needs, facilitating informed decisions regarding diet, exercise, and overall well-being. By prioritizing an integrated health strategy, January AI aims to transform the consumer health landscape, focusing on proactive management rather than reactive treatment.
Mosaic
Series A in 2021
Mosaic.tech, established in 2019 and based in San Diego, California, specializes in AI-powered financial planning and analysis (FP&A) software. The company combines big data and machine learning to offer predictive reporting capabilities, providing startups with enterprise-level tools and insights. Mosaic.tech's platform features one-click integrations, real-time analytics, and intuitive data visualization, enabling users to automate financial forecasts, report instantly, and collaborate effectively. This empowers clients to make informed decisions, time their strategies accurately, and drive business growth.
Gali Health
Seed Round in 2020
Gali Health, Inc. is a health technology company based in San Francisco, California, established in 2015. The company focuses on developing a mobile application named Gali, which serves as a personal health assistant designed to support individuals with chronic conditions. By leveraging collective intelligence, Gali enables users to proactively manage their health through crowdsourced personal health data and medically-validated insights. The application employs artificial intelligence to provide highly personalized support, addressing medical, lifestyle, and psychological aspects of living with chronic diseases. Gali Health aims to empower users by ensuring they do not feel isolated or powerless in managing their health, advancing consumer-driven healthcare through innovative technology and personalized health tracking.
BioAge Labs
Series C in 2020
BioAge Labs, Inc. is a biotechnology company focused on developing therapies to address aging and age-related diseases. The company utilizes a systems biology and artificial intelligence platform to identify key drug targets that influence aging and analyze extensive datasets to uncover the molecular drivers of age-related conditions. BioAge Labs is advancing several drug candidates, including BGE-117, a hypoxia-inducible factor prolyl hydroxylase inhibitor designed to activate genes involved in critical biological processes such as tissue regeneration and vascular remodeling. Additionally, BGE-175, an orally administered inhibitor of the prostaglandin D2 DP1 signaling pathway, aims to mitigate risks associated with immune aging and respiratory infections. Founded in 2015 and based in Richmond, California, BioAge Labs is committed to discovering and developing innovative treatments that harness the biology of human aging.
PicnicHealth
Series B in 2020
PicnicHealth is a company focused on simplifying access to medical records and utilizing data to advance medical research. It provides patients with a secure online dashboard that consolidates their medical records from various healthcare providers across the United States. This innovative platform allows individuals to manage their health information efficiently while also giving them the option to contribute their anonymized data for scientific research. By doing so, PicnicHealth enables life sciences researchers to gain insights into real-world disease management and treatment practices, enhancing the understanding of patient experiences beyond traditional clinical trials. The company has successfully assisted tens of thousands of patients and established partnerships with major biopharmaceutical firms, positioning itself as a key player in the evolving healthcare landscape.
Gali Health
Seed Round in 2020
Gali Health, Inc. is a health technology company based in San Francisco, California, established in 2015. The company focuses on developing a mobile application named Gali, which serves as a personal health assistant designed to support individuals with chronic conditions. By leveraging collective intelligence, Gali enables users to proactively manage their health through crowdsourced personal health data and medically-validated insights. The application employs artificial intelligence to provide highly personalized support, addressing medical, lifestyle, and psychological aspects of living with chronic diseases. Gali Health aims to empower users by ensuring they do not feel isolated or powerless in managing their health, advancing consumer-driven healthcare through innovative technology and personalized health tracking.
Clear Labs
Venture Round in 2020
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.
Crunchbase
Series C in 2019
Crunchbase is a comprehensive platform that assists over 80 million investors, analysts, and dealmakers in identifying and acting on private market opportunities through detailed analysis of company activities. It enables users to discover significant companies via its homepage, Crunchbase Scout, and search functionalities. The platform offers proprietary predictions and insights on organizational profiles, facilitating informed decision-making. Additionally, Crunchbase enhances team efficiency with various features such as data exports, administrative tools, and integrations. By providing unique private company intelligence, Crunchbase bridges the gap between data access and actionable business decisions, ultimately supporting users in navigating the complexities of the investment landscape.
Feel Therapeutics
Seed Round in 2019
Feel Therapeutics is a digital precision medicine company focused on improving mental health through objective data and passive monitoring. It develops physiological and digital biomarkers alongside therapeutics that aid in the diagnosis, management, and care of mental health conditions. The company's platform includes proprietary medical-grade wearables, such as a wristband equipped with five embedded sensors, which collect biometric data. This data is analyzed using advanced computational methods to create digital biomarkers. By integrating these technologies, Feel Therapeutics aims to provide users with evidence-based insights that enhance their mental well-being and foster the development of lasting positive emotional habits.
Gali Health
Seed Round in 2019
Gali Health, Inc. is a health technology company based in San Francisco, California, established in 2015. The company focuses on developing a mobile application named Gali, which serves as a personal health assistant designed to support individuals with chronic conditions. By leveraging collective intelligence, Gali enables users to proactively manage their health through crowdsourced personal health data and medically-validated insights. The application employs artificial intelligence to provide highly personalized support, addressing medical, lifestyle, and psychological aspects of living with chronic diseases. Gali Health aims to empower users by ensuring they do not feel isolated or powerless in managing their health, advancing consumer-driven healthcare through innovative technology and personalized health tracking.
BioAge Labs
Series B in 2019
BioAge Labs, Inc. is a biotechnology company focused on developing therapies to address aging and age-related diseases. The company utilizes a systems biology and artificial intelligence platform to identify key drug targets that influence aging and analyze extensive datasets to uncover the molecular drivers of age-related conditions. BioAge Labs is advancing several drug candidates, including BGE-117, a hypoxia-inducible factor prolyl hydroxylase inhibitor designed to activate genes involved in critical biological processes such as tissue regeneration and vascular remodeling. Additionally, BGE-175, an orally administered inhibitor of the prostaglandin D2 DP1 signaling pathway, aims to mitigate risks associated with immune aging and respiratory infections. Founded in 2015 and based in Richmond, California, BioAge Labs is committed to discovering and developing innovative treatments that harness the biology of human aging.
Clear Labs
Series B in 2018
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.
Gamalon
Series A in 2018
Gamalon, Inc. specializes in statistical machine learning solutions, focusing on Bayesian probabilistic programming languages. Founded in 2013 and based in Boston, Massachusetts, the company has developed an AI-driven machine intelligence technology that automates the writing and rewriting of its own Bayesian programs. This innovation allows businesses to convert unstructured text into structured data efficiently, enabling e-commerce and manufacturing sectors to train their systems with minimal data while achieving accuracy comparable to extensively trained neural networks. Additionally, Gamalon offers a conversational machine intelligence platform that interprets and summarizes customer messages, facilitating data-driven decision-making and enhancing customer experience.
Bluecore
Series C in 2017
Bluecore is an AI-driven multi-channel marketing platform that specializes in retail marketing. It leverages predictive intelligence to enhance the personalization and prioritization of marketing efforts. By consolidating consumer behavior data and product information, Bluecore provides a detailed understanding of each shopper's historical interactions and anticipated future behaviors with brands. The platform supports marketers in making informed decisions based on extensive data sets, optimizing customer engagement across various channels, including email, websites, display advertisements, and social media. With nearly 500 million shopper IDs and a vast product catalog, Bluecore plays a significant role in helping businesses acquire, retain, and expand their customer base.
TalkIQ
Series A in 2017
TalkIQ is a company that specializes in voice-to-text transcription and analytics, providing insights derived from customer conversations across various industries. Since its inception in 2014, TalkIQ has utilized advanced deep-learning algorithms and proprietary speech recognition technology to enhance business operations. Its platform features a user-friendly dashboard that synthesizes conversations, offering real-time recommendations and predictive analytics. This enables businesses to identify key moments during customer interactions, such as recognizing purchase intent and managing objections, ultimately optimizing sales processes and improving customer service. TalkIQ's solutions aim to enhance productivity by facilitating quick access to actionable data and insights. The company is supported by notable Silicon Valley venture capital firms and advised by experts with extensive experience in speech and language recognition.
BioAge Labs
Series A in 2017
BioAge Labs, Inc. is a biotechnology company focused on developing therapies to address aging and age-related diseases. The company utilizes a systems biology and artificial intelligence platform to identify key drug targets that influence aging and analyze extensive datasets to uncover the molecular drivers of age-related conditions. BioAge Labs is advancing several drug candidates, including BGE-117, a hypoxia-inducible factor prolyl hydroxylase inhibitor designed to activate genes involved in critical biological processes such as tissue regeneration and vascular remodeling. Additionally, BGE-175, an orally administered inhibitor of the prostaglandin D2 DP1 signaling pathway, aims to mitigate risks associated with immune aging and respiratory infections. Founded in 2015 and based in Richmond, California, BioAge Labs is committed to discovering and developing innovative treatments that harness the biology of human aging.
Crunchbase
Series B in 2017
Crunchbase is a comprehensive platform that assists over 80 million investors, analysts, and dealmakers in identifying and acting on private market opportunities through detailed analysis of company activities. It enables users to discover significant companies via its homepage, Crunchbase Scout, and search functionalities. The platform offers proprietary predictions and insights on organizational profiles, facilitating informed decision-making. Additionally, Crunchbase enhances team efficiency with various features such as data exports, administrative tools, and integrations. By providing unique private company intelligence, Crunchbase bridges the gap between data access and actionable business decisions, ultimately supporting users in navigating the complexities of the investment landscape.
Gamalon
Seed Round in 2017
Gamalon, Inc. specializes in statistical machine learning solutions, focusing on Bayesian probabilistic programming languages. Founded in 2013 and based in Boston, Massachusetts, the company has developed an AI-driven machine intelligence technology that automates the writing and rewriting of its own Bayesian programs. This innovation allows businesses to convert unstructured text into structured data efficiently, enabling e-commerce and manufacturing sectors to train their systems with minimal data while achieving accuracy comparable to extensively trained neural networks. Additionally, Gamalon offers a conversational machine intelligence platform that interprets and summarizes customer messages, facilitating data-driven decision-making and enhancing customer experience.
Dedrone
Series B in 2017
Dedrone GmbH specializes in drone detection solutions aimed at enhancing security against unauthorized aerial intrusions. Established in 2014 and headquartered in Kassel, Germany, the company offers its flagship product, DroneTracker, a multi-sensor system designed to identify and monitor unmanned aerial vehicles. This platform serves critical sectors such as data centers, airports, and prisons, providing early warnings of potential threats related to corporate espionage, smuggling, and terrorism. Utilizing machine learning and data fusion technology, Dedrone's system allows clients to customize their security measures according to their specific needs and threat levels. The company's products are distributed globally, addressing the growing vulnerabilities associated with advancements in consumer and commercial drone technology.
Clear Labs
Series B in 2016
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.
TalkIQ
Seed Round in 2016
TalkIQ is a company that specializes in voice-to-text transcription and analytics, providing insights derived from customer conversations across various industries. Since its inception in 2014, TalkIQ has utilized advanced deep-learning algorithms and proprietary speech recognition technology to enhance business operations. Its platform features a user-friendly dashboard that synthesizes conversations, offering real-time recommendations and predictive analytics. This enables businesses to identify key moments during customer interactions, such as recognizing purchase intent and managing objections, ultimately optimizing sales processes and improving customer service. TalkIQ's solutions aim to enhance productivity by facilitating quick access to actionable data and insights. The company is supported by notable Silicon Valley venture capital firms and advised by experts with extensive experience in speech and language recognition.
Gamalon
Venture Round in 2016
Gamalon, Inc. specializes in statistical machine learning solutions, focusing on Bayesian probabilistic programming languages. Founded in 2013 and based in Boston, Massachusetts, the company has developed an AI-driven machine intelligence technology that automates the writing and rewriting of its own Bayesian programs. This innovation allows businesses to convert unstructured text into structured data efficiently, enabling e-commerce and manufacturing sectors to train their systems with minimal data while achieving accuracy comparable to extensively trained neural networks. Additionally, Gamalon offers a conversational machine intelligence platform that interprets and summarizes customer messages, facilitating data-driven decision-making and enhancing customer experience.
Emailage
Series A in 2016
Emailage Corp., established in 2012 and headquartered in Chandler, Arizona, specializes in fraud prevention and identity verification solutions. It leverages machine learning and proprietary algorithms to assess digital entity risks in real-time, helping businesses across various industries, such as banking, e-commerce, and gaming, to confirm identities, increase approvals, and reduce fraud losses. The company's core products, EmailRisk Score and RapidRisk Score, provide predictive fraud risk analysis and enable companies to identify and stop fraudulent transactions, ultimately enhancing customer experience and saving operational costs. Emailage operates globally and is a subsidiary of LexisNexis Risk Solutions Inc.
Zodiac
Seed Round in 2016
Zodiac Inc. specializes in predictive analytics solutions that forecast individualized customer lifetime value by leveraging real-time sales data. Founded in 2015 and headquartered in Philadelphia, Pennsylvania, the company aims to transform businesses into customer-centric organizations by providing insights into customer behavior. Zodiac’s cloud-based platform employs advanced data models and customer analytics to predict future behaviors, enabling marketers to make informed decisions about campaign optimization and sales forecasting. By focusing on individual customer metrics, Zodiac helps organizations acquire and retain high-value customers while minimizing ineffective spending. The company operates as a subsidiary of NIKE, Inc.
Guardant Health
Series D in 2016
Guardant Health, Inc. is a precision oncology company headquartered in Redwood City, California, specializing in liquid biopsy tests for cancer diagnosis and treatment. The company provides a range of blood tests, including Guardant360, which measures various cancer-related genes for advanced stage cancer treatment selection, and GuardantOMNI, a broader gene panel that supports immuno-oncology research. Additionally, Guardant Health offers LUNAR-1 for detecting minimal residual disease and recurrence in cancer survivors, along with the development of LUNAR-2 for early cancer detection in high-risk individuals. The company also provides development services such as companion diagnostic development and clinical trial support to biopharmaceutical firms and medical institutions. Founded in 2011, Guardant Health is recognized for its innovative approach to addressing unmet needs in oncology through advanced technology and analytics.
Ascend.io
Seed Round in 2015
Ascend.io, based in Palo Alto, California, offers an advanced platform designed to streamline big data analytics and engineering workflows. The platform integrates essential capabilities such as data ingestion, transformation, delivery, orchestration, and observability into a unified solution, enabling data teams to operate significantly faster. By leveraging declarative configurations and automation, Ascend.io manages cloud infrastructure, optimizes data pipelines, and reduces maintenance throughout the data lifecycle. This innovative approach supports business managers in initiating projects and making informed decisions by simplifying connections to various applications. Recognized as a 2021 Gartner Cool Vendor, Ascend.io is supported by prominent venture capital firms and notable advisors in the tech industry.
Bluecore
Series B in 2015
Bluecore is an AI-driven multi-channel marketing platform that specializes in retail marketing. It leverages predictive intelligence to enhance the personalization and prioritization of marketing efforts. By consolidating consumer behavior data and product information, Bluecore provides a detailed understanding of each shopper's historical interactions and anticipated future behaviors with brands. The platform supports marketers in making informed decisions based on extensive data sets, optimizing customer engagement across various channels, including email, websites, display advertisements, and social media. With nearly 500 million shopper IDs and a vast product catalog, Bluecore plays a significant role in helping businesses acquire, retain, and expand their customer base.
Crunchbase
Series A in 2015
Crunchbase is a comprehensive platform that assists over 80 million investors, analysts, and dealmakers in identifying and acting on private market opportunities through detailed analysis of company activities. It enables users to discover significant companies via its homepage, Crunchbase Scout, and search functionalities. The platform offers proprietary predictions and insights on organizational profiles, facilitating informed decision-making. Additionally, Crunchbase enhances team efficiency with various features such as data exports, administrative tools, and integrations. By providing unique private company intelligence, Crunchbase bridges the gap between data access and actionable business decisions, ultimately supporting users in navigating the complexities of the investment landscape.
Civitas Learning
Series D in 2015
Civitas Learning, Inc. is an education technology company that provides a predictive analytics platform aimed at enhancing student success across higher education institutions. Founded in 2011 and based in Austin, Texas, the company offers a suite of tools designed to aggregate and analyze disparate data sources throughout the student journey. Its student insights platform enables institutions to gain a comprehensive view of student experiences, while applications like Illume and Inspire for Faculty deliver real-time insights into student engagement and predictive student flow. Civitas Learning also offers Hoot.me, a crowd-sourced question-and-answer platform, and College Scheduler, which simplifies degree completion processes for students. The company serves approximately 375 colleges and universities, impacting nearly 8 million students across the United States, the United Kingdom, Ireland, and Mexico, with the goal of helping institutions graduate an additional million students annually by 2025.
Clear Labs
Series A in 2015
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.
Petasense
Seed Round in 2015
Petasense Inc., founded in 2014 and headquartered in Foster City, California, is an Industrial IoT startup focused on enhancing the reliability of industrial machines. The company provides an end-to-end solution featuring a patent-pending wireless vibration sensor, cloud software, and machine learning analytics. This technology allows customers to monitor and predict the health of critical machinery in real-time, thereby reducing unplanned downtime and lowering repair costs. Petasense serves a diverse clientele, including prominent organizations such as JLL, C&W Services, Silicon Valley Power, and Stanford University. Founded by experienced entrepreneurs Abhinav Khushraj and Arun Santhebennur, the company is supported by notable investors like True Ventures and Felicis Ventures.
Guardant Health
Series C in 2015
Guardant Health, Inc. is a precision oncology company headquartered in Redwood City, California, specializing in liquid biopsy tests for cancer diagnosis and treatment. The company provides a range of blood tests, including Guardant360, which measures various cancer-related genes for advanced stage cancer treatment selection, and GuardantOMNI, a broader gene panel that supports immuno-oncology research. Additionally, Guardant Health offers LUNAR-1 for detecting minimal residual disease and recurrence in cancer survivors, along with the development of LUNAR-2 for early cancer detection in high-risk individuals. The company also provides development services such as companion diagnostic development and clinical trial support to biopharmaceutical firms and medical institutions. Founded in 2011, Guardant Health is recognized for its innovative approach to addressing unmet needs in oncology through advanced technology and analytics.
Bluecore
Series A in 2015
Bluecore is an AI-driven multi-channel marketing platform that specializes in retail marketing. It leverages predictive intelligence to enhance the personalization and prioritization of marketing efforts. By consolidating consumer behavior data and product information, Bluecore provides a detailed understanding of each shopper's historical interactions and anticipated future behaviors with brands. The platform supports marketers in making informed decisions based on extensive data sets, optimizing customer engagement across various channels, including email, websites, display advertisements, and social media. With nearly 500 million shopper IDs and a vast product catalog, Bluecore plays a significant role in helping businesses acquire, retain, and expand their customer base.
Civitas Learning
Series C in 2015
Civitas Learning, Inc. is an education technology company that provides a predictive analytics platform aimed at enhancing student success across higher education institutions. Founded in 2011 and based in Austin, Texas, the company offers a suite of tools designed to aggregate and analyze disparate data sources throughout the student journey. Its student insights platform enables institutions to gain a comprehensive view of student experiences, while applications like Illume and Inspire for Faculty deliver real-time insights into student engagement and predictive student flow. Civitas Learning also offers Hoot.me, a crowd-sourced question-and-answer platform, and College Scheduler, which simplifies degree completion processes for students. The company serves approximately 375 colleges and universities, impacting nearly 8 million students across the United States, the United Kingdom, Ireland, and Mexico, with the goal of helping institutions graduate an additional million students annually by 2025.
RelateIQ
Series C in 2014
RelateIQ, now known as SalesforceIQ, is a provider of a professional relationship management platform designed to enhance customer relationship management. The platform automatically captures communication data from various sources, including email, phone calls, calendars, and social networks, allowing users to manage and analyze their interactions with sales prospects effectively. By leveraging advanced data science capabilities, RelateIQ delivers valuable insights that help users close deals more efficiently. The platform is accessible across multiple devices, including mobile applications and browser extensions, facilitating collaboration among teams. Ultimately, RelateIQ aims to drive revenue growth while streamlining workflows, making the sales process more efficient and less burdensome for its users.
EPINOMICS
Funding Round in 2014
Epinomics Inc. specializes in advancing personalized medicine by leveraging big data analytics and proprietary epigenomics technology. Founded in 2013 and located in Menlo Park, California, the company focuses on decoding the human genome to enhance drug development and clinical applications. By utilizing innovative DNA sequencing technology, Epinomics aims to improve existing methodologies in the field, facilitating deeper scientific research and the development of clinical applications. As of March 31, 2018, Epinomics operates as a subsidiary of 10X Genomics, Inc., furthering its mission to revolutionize healthcare through precision medicine.
Iodine
Seed Round in 2014
Iodine, Inc. is a San Francisco-based company that specializes in providing online healthcare data to empower consumers in making informed decisions about medications. Founded in 2013, the company utilizes clinical data from open government datasets, such as those from the FDA and CMS, to develop tools that enhance drug-related decision-making and adherence to prescribed therapies. One of its key offerings is Med Labels, which allows users to search and read FDA product labels online. Iodine addresses a significant gap in the market, as many internet users seek reliable drug information but often find existing resources inadequate. By focusing on user needs rather than advertising revenue, Iodine aims to improve health outcomes and optimize therapeutic choices for individuals navigating their healthcare options.
Kissmetrics
Series B in 2013
Kissmetrics is a company specializing in customer engagement automation, founded in 2008. It provides a platform that offers behavioral analytics, segmentation, and email campaign automation, all integrated into one system. The platform helps businesses identify, understand, and improve key metrics that drive their online operations. By connecting experiment results to existing business metrics and providing insights through a familiar dashboard, Kissmetrics assists companies in measuring, growing, and monetizing their customer base across multiple digital devices. The company is run by a team of designers, developers, and entrepreneurs dedicated to supporting online businesses.
Civitas Learning
Series B in 2013
Civitas Learning, Inc. is an education technology company that provides a predictive analytics platform aimed at enhancing student success across higher education institutions. Founded in 2011 and based in Austin, Texas, the company offers a suite of tools designed to aggregate and analyze disparate data sources throughout the student journey. Its student insights platform enables institutions to gain a comprehensive view of student experiences, while applications like Illume and Inspire for Faculty deliver real-time insights into student engagement and predictive student flow. Civitas Learning also offers Hoot.me, a crowd-sourced question-and-answer platform, and College Scheduler, which simplifies degree completion processes for students. The company serves approximately 375 colleges and universities, impacting nearly 8 million students across the United States, the United Kingdom, Ireland, and Mexico, with the goal of helping institutions graduate an additional million students annually by 2025.
PlotWatt
Series A in 2012
PlotWatt, Inc. is an energy analytics software company based in Durham, North Carolina, serving customers in the United States, Canada, and New Zealand. Founded in 2008, PlotWatt employs machine-learning algorithms to analyze energy usage data, providing actionable insights that help both residential and commercial clients enhance their energy efficiency and reduce costs. The platform is particularly beneficial for multi-location businesses, offering site-by-site comparative analysis and operational benchmarking to optimize energy management. By delivering tailored recommendations without the need for monitoring individual appliances, PlotWatt's cloud-based solutions empower customers to make informed decisions about their energy consumption, ultimately promoting sustainability and cost savings. The company operates as a subsidiary of American Efficient, Inc.
Optimizely
Seed Round in 2012
Optimizely, Inc. is a company that operates a website optimization platform designed for A/B testing, multivariate testing, and website personalization, catering to both technical and non-technical users. Founded in 2009 and headquartered in San Francisco, California, it also has offices in Amsterdam, Sydney, and Austin. The platform allows organizations to conduct experiments that facilitate data-driven decision-making and is available in multiple languages, making it accessible to a global audience. Optimizely's offerings include web content management, digital experience software, and integrated capabilities for content, commerce, multi-channel marketing, and predictive analytics. The company serves a diverse clientele, including agencies, developers, e-commerce businesses, enterprises, publishers, and small businesses primarily in the United States, Germany, the United Kingdom, and Spain. Optimizely, formerly known as Spreadly, operates as a subsidiary of EPiServer AB.
PlotWatt
Seed Round in 2011
PlotWatt, Inc. is an energy analytics software company based in Durham, North Carolina, serving customers in the United States, Canada, and New Zealand. Founded in 2008, PlotWatt employs machine-learning algorithms to analyze energy usage data, providing actionable insights that help both residential and commercial clients enhance their energy efficiency and reduce costs. The platform is particularly beneficial for multi-location businesses, offering site-by-site comparative analysis and operational benchmarking to optimize energy management. By delivering tailored recommendations without the need for monitoring individual appliances, PlotWatt's cloud-based solutions empower customers to make informed decisions about their energy consumption, ultimately promoting sustainability and cost savings. The company operates as a subsidiary of American Efficient, Inc.
Kissmetrics
Series A in 2009
Kissmetrics is a company specializing in customer engagement automation, founded in 2008. It provides a platform that offers behavioral analytics, segmentation, and email campaign automation, all integrated into one system. The platform helps businesses identify, understand, and improve key metrics that drive their online operations. By connecting experiment results to existing business metrics and providing insights through a familiar dashboard, Kissmetrics assists companies in measuring, growing, and monetizing their customer base across multiple digital devices. The company is run by a team of designers, developers, and entrepreneurs dedicated to supporting online businesses.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.